Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$483K Sell
5,324
-30,354
-85% -$2.83M 0.03% 179
2024
Q4
$3.58M Buy
35,678
+3,039
+9% +$313K 0.2% 91
2024
Q3
$3.73M Buy
32,639
+16,287
+100% +$1.93M 0.25% 79
2024
Q2
$2.04M Sell
16,352
-566
-3% -$72.9K 0.15% 96
2024
Q1
$2.25M Sell
16,918
-21,196
-56% -$2.61M 0.21% 94
2023
Q4
$4.18M Sell
38,114
-1,327
-3% -$138K 0.41% 79
2023
Q3
$4.09M Sell
39,441
-28,565
-42% -$3.08M 0.43% 72
2023
Q2
$7.9M Buy
68,006
+474
+0.7% +$53.8K 0.71% 45
2023
Q1
$7.23M Buy
67,532
+32,543
+93% +$3.51M 0.68% 51
2022
Q4
$3.88M Buy
34,989
+32,260
+1,182% +$3.3M 0.44% 71
2022
Q3
$236K Sell
2,729
-1,520
-36% -$136K 0.03% 167
2022
Q2
$389K Sell
4,249
-231
-5% -$20.5K 0.06% 146
2022
Q1
$368K Sell
4,480
-1,131
-20% -$89.2K 0.04% 182
2021
Q4
$430K Sell
5,611
-837
-13% -$66.7K 0.04% 165
2021
Q3
$484K Sell
6,448
-745
-10% -$56.7K 0.06% 161
2021
Q2
$559K Sell
7,193
-7
-0.1% -$521 0.07% 161
2021
Q1
$530K Buy
7,200
+657
+10% +$48.5K 0.11% 151
2020
Q4
$511K Buy
6,543
+83
+1% +$6.35K 0.11% 147
2020
Q3
$511K Sell
6,460
-420
-6% -$32.9K 0.08% 145
2020
Q2
$508K Buy
6,880
+77
+1% +$5.8K 0.09% 149
2020
Q1
$499K Buy
6,803
+73
+1% +$5.74K 0.11% 143
2019
Q4
$584K Buy
6,730
+164
+2% +$13.5K 0.09% 152
2019
Q3
$527K Sell
6,566
-5,700
-46% -$457K 0.09% 144
2019
Q2
$982K Buy
+12,266
New +$939K 0.14% 135
2018
Q1
Sell
-23,227
Closed -$1.25M 250
2017
Q4
$1.25M Buy
23,227
+653
+3% +$36.2K 0.23% 137
2017
Q3
$1.38M Buy
+22,574
New +$1.37M 0.48% 72
2017
Q2
Sell
-20,601
Closed -$1.25M 115
2017
Q1
$1.25M Buy
20,601
+225
+1% +$13.7K 0.47% 65
2016
Q4
$1.15M Buy
20,376
+2,005
+11% +$117K 0.45% 70
2016
Q3
$1.09M Sell
18,371
-807
-4% -$47.2K 0.47% 72
2016
Q2
$1.05M Buy
+19,178
New +$1.02M 0.44% 76

Other funds holding MRK

Transform Wealth's MRK Position: Q1 2025 in Review

Transform Wealth reduced its Merck (MRK) stake by 85% in Q1 2025, selling an estimated $2.83M and leaving 5,324 shares worth $483K. The position accounts for 0.03% of the portfolio, ranked #179.

Transform Wealth first reported a position in MRK in Q2 2016 and has held it in 30 quarters since. The position peaked at $7.9M in Q2 2023. 3,448 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Transform Wealth held 5,324 shares of Merck worth $483K as of Q1 2025.
  • Transform Wealth sold 30,354 Merck shares in Q1 2025, an estimated $2.83M.
  • Merck made up 0.03% of Transform Wealth's portfolio in Q1 2025, its #179 holding.
  • Transform Wealth first reported a position in Merck in Q2 2016 and has held it in 30 quarters since.
  • Transform Wealth's Merck position peaked at $7.9M in Q2 2023.
  • 3,448 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Transform Wealth's 13F filing for Q1 2025, filed 15 Apr 2025.